Article Text

Download PDFPDF

Palliation of dyspnoea in advanced COPD: revisiting a role for opioids
  1. G Rocker1,2,
  2. R Horton2,
  3. D Currow3,
  4. D Goodridge4,
  5. J Young5,
  6. S Booth6
  1. 1
    Division of Respirology, QEII Health Science Centre and Dalhousie University, Halifax Nova Scotia, Canada
  2. 2
    Division of Palliative Medicine, QEII Health Science Centre and Dalhousie University, Halifax Nova Scotia, Canada
  3. 3
    Flinders Centre for Clinical Change, Flinders University, Australia
  4. 4
    College of Nursing, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
  5. 5
    New Brunswick Extra Mural Program, 73 Milltown Blvd, Suite 100, St Stephen, New Brunswick, Canada
  6. 6
    Addenbrookes NHS Trust, Cambridge, UK
  1. Correspondence to Dr G M Rocker, #4457 Halifax Infirmary, 1796 Summer St, Halifax, Nova Scotia, Canada B3H 3A7; gmrocker{at}dal.ca

Abstract

Chronic obstructive pulmonary disease (COPD) will be the third leading cause of death worldwide by 2020. The burdens of this increasingly prevalent illness borne by patients, their family caregivers and the healthcare system are substantial. Dyspnoea as the predominant symptom becomes increasingly difficult to palliate as COPD progresses through advanced stages and, for 50% of patients, can become refractory to conventional treatment. This narrative review focuses on the potential role for carefully initiated and titrated opioids in the management of dyspnoea for patients with advanced COPD who are not yet in a terminal stage, yet struggle with symptoms that reflect underlying mechanisms of dyspnoea that lend themselves to this approach. The many barriers that currently exist to the provision of opioids in this setting are addressed, and recommendations are provided for an approach that should engender confidence among patients, their caregivers and the physicians who treat them.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Provenance and Peer review Not commissioned; externally peer reviewed,

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.